Announcements Trials

Browse Landscape

Status

Recruiting 31 Completed 26 Active not recruiting 16 Withdrawn 8 Terminated 8 Unknown 5 Suspended 3 Not yet recruiting 3 Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 2 Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Fluorodeoxyglucose F18 3 pembrolizumab 2 sacituzumab govitecan 1 ibrutinib 1 erdafitinib 1 enzalutamide 1 enfortumab vedotin 1 dynorphin-converting endopeptidase 1 avelumab 1 apixaban 1 Vinblastine 1 Surveys and Questionnaires 1 Specimen Handling 1 Radiosurgery 1 Pancreatectomy 1 Paclitaxel 1 Nivolumab 1 Methotrexate 1 Magnetic Resonance Imaging 1 JNJ-64619178 1 JNJ-64264681 1 Inosine Monophosphate 1 Health Information Exchange 1 Genetic Testing 1 Genetic Counseling 1 Gemcitabine 1 Focus Groups 1 Enoxaparin 1 Docetaxel 1 Cystoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Biopsy × Genitourinary × Clear all

NCT06424275 2025-08-15

PRAISE-U

European Association of Urology Research Foundation

Enrolling by invitation

20,000 enrolled

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡